Jennie Kwon, DO, MSCI appointed to serve on IDSA committee

Jennie Kwon, DO, MSCI

Jennie Kwon, DO, MSCI, assistant professor of medicine has recently been appointed to the Infectious Disease Society of America (IDSA) Antimicrobial Resistance Committee Committee. The Antimicrobial Resistance Committee serves to advance, through public policy and advocacy, the development of new antimicrobial agents where unmet need exists and the reduction of occurrence of antimicrobial resistance. The committee […]

Congratulations to our newly elected IDSA Fellows

We are proud to announce the following faculty, each who have been named a Fellow by the Infectious Diseases Society of America, the nation’s leading infectious diseases professional society. Fellowship in IDSA is one of the highest honors in the field of infectious diseases. It recognizes distinguished clinicians and scientists from the United States and […]

Congratulations, Drs. Caline Mattar and Aaloke Mody, on appointments to IDSA global health committee

Caline Mattar, MD (right) and Aaloke Mody, MD

Caline Mattar, MD, assistant professor of medicine and Aaloke Mody, MD, assistant professor of medicine both have been appointed to the Infectious Diseases Society of America (IDSA) Global Health Committee. Dr. Mattar’s interests are in antimicrobial resistance and infection prevention in resource limited settings, global and international health, infectious diseases in pregnancy, currently COVID-19. Dr. Mody […]

Drs. Kwon and Babcock reveal vaccine effectiveness in health care professionals in a publication in NEJM

Estimated Adjusted Effectiveness of mRNA Vaccines against Covid-19 among Health Care Personnel According to Follow-up Time after Receipt of the Second Dose. To evaluate evidence of waning of vaccine effect, we estimated effectiveness every 2 weeks during the 14 total weeks of follow-up available immediately after receipt of the second dose (Figure 1). The point estimate of vaccine effectiveness, assessed in 2-week intervals, was highest during weeks 3 and 4 after receipt of the second dose (96.3%; 95% CI, 92.5 to 98.2). The point estimates were lower during weeks 9 through 14, but the 95% confidence intervals were wide and overlapping.

Hilary Babcock, MD, MPH, professor of medicine and Jennie Kwon, DO, MSCI, assistant professor of medicine participated in a CDC led multicenter study, published in the New England Journal of Medicine, showing that the Pfizer and Moderna COVID vaccines were highly effective under real-world conditions in preventing symptomatic COVID19 in health care personnel. Drs. Kwon and […]

Nathan Nolan, MD, and colleagues will present workshop at AAIMW22

Dr. Nathan Nolan, instructor in medicine, division of infectious diseases, along with Frank O’Brien, MBBCh, MRCPI, assistant professor of medicine, division of nephrology and Lisa Zickuhr, MD, assistant professor of medicine, division of rheumatology, submitted a workshop proposal for the Alliance for Academic Internal Medicine Week 2022 (AIMW22). Their submission,  “Interprofessional, Multidisciplinary Case Conferences: A Novel Approach […]

IDSA appoints Jennie Kwon, DO, MSCI to serve on two committees

Jennie Kwon, DO, MSCI

Jennie Kwon, DO, MSCI, assistant professor of medicine has recently been appointed to the Infectious Disease Society of America (IDSA) Antimicrobial Resistance Committee and Awards Committee. The Antimicrobial Resistance Committee serves to advance, through public policy and advocacy, the development of new antimicrobial agents where unmet need exists and the reduction of occurrence of antimicrobial resistance. […]

The Infectious Diseases Division Celebrates Women in Medicine

Each September, the AMA Women Physicians Section (WPS) honors physicians who have offered their time, wisdom and support to advance women with careers in medicine. The ID Division recognizes all the women physicians, researchers, residents, fellows and medical students working to make health care more equitable. We celebrate these trailblazers during Women in Medicine month. […]

Hilary Reno, MD, PhD, FIDSA, an author of recent STI Treatment Guidelines 2021 also co-authors “A Guide to Taking a Sexual History”

Associate professor of medicine, Dr. Hilary Reno, is a co-author of the recently released Sexually Transmitted Infections Treatment Guidelines, 2021 (cdc.gov). The guidelines provide current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 guidance. Although the new guidelines emphasize treatment, prevention strategies and diagnostic recommendations are also discussed. CDC’s Sexually Transmitted Infections (STI) […]

Andrej Spec, MD, MSCI, FECMM selected to lead the update of the Histoplasma guidelines by the Infectious Disease Society of America (IDSA)

Andrej Spec, MD

Andrej Spec, MD, MSCI, FECMM has been selected to lead the update of the Histoplasma guidelines by the Infectious Disease Society of America (IDSA); the first update since 2007. The guidelines haven’t been updated since 2007. Dr Spec was chosen among a large field of candidates based on his research in histoplasmosis. Most recently he […]

Hilary Babcock, MD, MPH and Jennie Kwon, DO, MSCI are co-authors of MMRW early release of reports on COVID-19 Hospitalizations and Vaccine Effectiveness (Links to an external site)

Real-world evaluations have demonstrated high effectiveness of vaccines against COVID-19–associated hospitalizations (1–4) measured shortly after vaccination; longer follow-up is needed to assess durability of protection. In an evaluation at 21 hospitals in 18 states, the duration of mRNA vaccine (Pfizer-BioNTech or Moderna) effectiveness (VE) against COVID-19–associated hospitalizations was assessed among adults aged ≥18 years. Among […]

Beating the clock on ticks and tick-borne illnesses – infectious disease clinic medical director Thomas Bailey, MD, explains

Weather conditions this summer are resulting in a very active tick season, especially in the Midwest. And where there are ticks, the diseases they carry are not far behind – ehrlichiosis, Rocky Mountain spotted fever, tularemia, Heartland virus, and Bourbon virus. Washington University physician and infectious disease clinic medical director Thomas Bailey, MD, explains, “While many […]

ID Fellows create video to show prospective fellow candidates what fellowship is like at WashU

During the COVID-19 pandemic, Washington University School of Medicine in St. Louis is prepared to conduct virtual interviews of potential candidates to join our ID fellowship program. Since candidates are not visiting onsite, our fellows decided to create a video that shows canididates around the medical campus while they share what it is like to […]

Rachel Presti, MD, PhD uses ICTS resources for COVID-19 research and clinical trial efforts

The CTSA program was developed to accelerate new treatments from the lab to patients, enabled to a large extent by patients participating in and benefiting from clinical trials. Clinical trials provide that needed bridge from human subjects to hypotheses to treatments that can directly benefit human health. And, never has this connection been more critical […]

Jeff Henderson, MD, PhD lead author of study that shows blood cancer patients with COVID-19 fare better with convalescent plasma (Links to an external site)

Retrospective study also indicates outcomes of critically ill patients in ICU improve when given antibodies from recovered COVID-19 patients A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus.

Congratulations to our class of 2021 graduating fellows!

Program Directors and Graduates 2021 (l-r) Dr. Nigar Kirmani, program director, Drs. Patrick Mazi, Joseph Cherabie, Miguel Chavez, Nathan Nolan, Sasinuch Rutjanawech, and Gerome Escota, MD, program co-director.

We are so proud of this graduating class of fellows. Their achievements are many and mentioned below in a brief synopsis of each fellow. Miguel Chavez, MD, MSc is the recipient of the 2021 SHEA Jonathan Freeman Scholarship Award, has published 2 peer reviewed articles, and presented 3 posters (healthcare epidemiology, microbiology, fungal infection and […]

Mild COVID-19 induces lasting antibody protection (Links to an external site)

Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.

Podcast: What to make of CDC’s new masking guidelines

The latest episode of the “Show Me the Science” podcast focuses on the CDC’s new masking guidelines. Guest William G. Powderly, MD, the Larry J. Shapiro Director of the Institute for Public Health and co-director of the Division of Infectious Diseases at WashU Med, says the new guidelines provide evidence that, for many fully vaccinated […]

Washington University Clinical Trials Unit to participate in the first polyclonal antibody for treatment of COVID-19

ACTG Adds First Polyclonal Antibody to ACTIV-2 Outpatient Treatment Study for COVID-19 The AIDS Clinical Trials Group (ACTG), the largest global HIV research   network, today announced the addition SAB-185, a polyclonal antibody therapy, to the COVID-19 outpatient treatment study, ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 […]